Health Canada drug identification number

DIN 02509733 — INCRELEX 10 MG

INCRELEX is a solution of Mecasermin marketed by ESTEVE PHARMACEUTICALS S.A.. The full Mecasermin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02509733
Brand name
INCRELEX
Active ingredient
Mecasermin
Strength
10 MG
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Manufacturer
ESTEVE PHARMACEUTICALS S.A.
Health Canada status
MARKETED
Drug class
Recombinant human insulin-like growth factor-1 (IGF-1) analogue

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.